» NicOx Announces Initiation Of First Phase 1 Study Of Investigational Nitric Oxide-Donating Agent In Hypertensive Patients By Merck & Co., Inc.
NicOx S.A. (Eurolist: COX) announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies’…